Fye K H, Hancock D, Moutsopoulos H, Humes H D, Arieff A I
Arch Intern Med. 1976 Sep;136(9):995-9.
Two patients developed acute renal failure; creatinine clearances fell to 13 and 34 ml/min, respectively, and one patient was oliguric. Renal biopsies in both patients gave results that were compatible with rapidly progressive glomerulonephritis (RPGN). Both patients were treated with low-dosage heparin sodium infusion (8,000 units/day) and prednisone for two to four weeks, followed by oral anticoagulant (warfarin) and antithrombotic agents (dipyridamole). In the two patients, creatinine clearance rose to at least 60 ml/min, and no bleeding complications were observed. Repeat renal biopsy specimens that were obtained after three to six months of treatment showed no evidence of active glomerulonephritis in either patient, but there was extensive scarring and fibrosis. Low-dosage heparin infusion may arrest and partially reverse the renal failure associated with RPGN in some cases, while avoiding the bleeding complications that are frequently observed in patients treated with larger dosages of heparin.
两名患者出现急性肾衰竭;肌酐清除率分别降至13和34 ml/分钟,其中一名患者少尿。两名患者的肾活检结果均符合快速进展性肾小球肾炎(RPGN)。两名患者均接受低剂量肝素钠输注(8000单位/天)和泼尼松治疗两至四周,随后口服抗凝剂(华法林)和抗血栓药物(双嘧达莫)。在这两名患者中,肌酐清除率升至至少60 ml/分钟,且未观察到出血并发症。治疗三至六个月后获取的重复肾活检标本显示,两名患者均无活动性肾小球肾炎证据,但有广泛的瘢痕形成和纤维化。低剂量肝素输注在某些情况下可能阻止并部分逆转与RPGN相关的肾衰竭,同时避免在接受较大剂量肝素治疗的患者中经常观察到的出血并发症。